Preoperative and Postoperative Platelet-Lymphocyte Ratio Is a Prognostic Marker for Patients With Soft Tissue Sarcoma Treated With Curative Resection
- PMID: 38936914
- DOI: 10.21873/invivo.13663
Preoperative and Postoperative Platelet-Lymphocyte Ratio Is a Prognostic Marker for Patients With Soft Tissue Sarcoma Treated With Curative Resection
Abstract
Background/aim: Systemic inflammation has been implicated in the development and progression of cancer. Inflammatory markers have been identified as prognostic indicators in numerous malignancies. This study explored the prognostic relevance of the initial and postoperative neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) on relapse-free survival (RFS) and overall survival (OS) in patients with soft-tissue sarcoma (STS) who underwent curative resection.
Patients and methods: We included 89 patients with STS who underwent extensive and radical resection at the Kyungpook National University Chilgok Hospital between 2004 and 2018. Kaplan-Meier curves for RFS and OS were calculated using multivariate Cox proportional models.
Results: A total of 67 (75.3%) patients demonstrated a high initial NLR (≥4.1) and 65 (75.3%) showed a high initial PLR (≥231). In the univariate and multivariate analyses, an elevated initial PLR ratio was significantly associated with a decreased RFS (p=0.017) and OS (p=0.003). Patients with a high PLR (PLR >231) had a median RFS of 24 months, whereas those with a low PLR (PLR ≤231) had a median RFS of 96 months. The median OS was 50 and 298 months for the high PLR and low PLR groups, respectively. Furthermore, a high postoperative PLR ratio was associated with a decreased RFS (p=0.001) and OS (p=0.038).
Conclusion: Preoperative and postoperative PLR ratio can be used as a cost-effective prognostic marker for oncologic outcomes in patients with STS who undergo surgery.
Keywords: PLR; Soft-tissue sarcoma; prognostic marker.
Copyright © 2024, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Similar articles
-
Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor.BMC Gastroenterol. 2020 Apr 22;20(1):124. doi: 10.1186/s12876-020-01275-2. BMC Gastroenterol. 2020. PMID: 32321434 Free PMC article.
-
Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.Int J Surg. 2018 Aug;56:320-327. doi: 10.1016/j.ijsu.2018.06.037. Epub 2018 Jun 30. Int J Surg. 2018. PMID: 29969732
-
Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.Cancer Biomark. 2016;16(3):333-42. doi: 10.3233/CBM-160571. Cancer Biomark. 2016. PMID: 26835589 Review.
-
Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.Surgery. 2016 Apr;159(4):1146-56. doi: 10.1016/j.surg.2015.10.021. Epub 2015 Dec 11. Surgery. 2016. PMID: 26688506
-
Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.BMC Cancer. 2015 Oct 2;15:648. doi: 10.1186/s12885-015-1654-6. BMC Cancer. 2015. PMID: 26432433 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical